Stock Futures Give Up Most Gains to Trade Near Flat Ahead of Open

U.S. stock futures gave up most of the gains made earlier on M&A activity and pointed to markets opening near unchanged on Tuesday.

New York Federal Reserve Bank President William Dudley was speaking in Newark, N.J., this morning. On Monday, Dudley suggested the Federal Reserve may hold off on raising interest rates after the weak jobs report on Friday. Meanwhile, Minneapolis Fed President Naryana Kocherlakota will speak in Bismarck, N.D.

Also out today, at 10:00 a.m. is the Labor Department's Job Openings and Labor Turnover Survey, which is expected to show 5.01 million job openings in February over 4.998 million in January.

In equities, package delivery and logistics firm FedEx ( FDX ) said it has agreed to buy Dutch rival TNT Express for EUR8 per share, or about $4.8 billion in total. FDX was higher 5.3% in recent pre-market trade. Meanwhile, Informatica ( INFA ), a provider of enterprise data-integration software and services, said it has agreed to be acquired by a company controlled by the Permira funds and Canada Pension Plan Investment Board for approximately $5.3 billion. INFA was up 5% after coming off its halt.


-Dow Jones Industrial up 0.10%

-S&P 500 futures up 0.07%

-Nasdaq 100 futures up 0.09%

-Nasdaq 100 pre-market indicator up 0.15%


Nikkei up 1.25%

Hang Seng up 0.77%

Shanghai Composite up 2.15%

FTSE-100 up 1.45%

DAX-30 up 1.23%


(+/-) Large cap tech: mixed

(+) Chip stocks: unchanged to higher

(+/-) Software stocks: mixed

(+) Hardware stocks: unchanged to higher

(+) Internet stocks: unchanged to higher

(+/-) Drug stocks: mixed

(+) Financial stocks: unchanged to higher

(+/-) Retail stocks: mixed

(+) Industrial stocks: unchanged to higher

(+) Airlines: unchanged to higher

(-) Autos: unchanged to lower


(+) CYTX (+5.3%) Gets orphan drug status for cellular therapeutics in EU

(+) BIND (+12.5%) Extends Monday's gains after Pfizer cancer drug development deal extended

(+) AXTA (+4.9%) Berkshire Hathaway buys 20 million shares of co at $28 each

(+) CLVS (+9.1%) Ovarian cancer treatment wins 'breakthrough' status by FDA

(+) BLDP (+11.1%) Demonstrates first hydrogen fuel cell tram in China

(+) GBX (-7.1%) Fiscal Q2 results beat views; raises FY guidance

(+) SHPG (+2.6%) Agrees with FDA to test ADHD drug candidate in pediatric patients

(+) ONCY (+5.5%) Files for orphan drug designation for gastric cancer treatment

(+) CTRP (+3.0%) Piper Jaffray upgrades to overweight vs neutral; ups PT

(+) JPM (+0.7%) Bernstein upgrades to outperform vs market perform, raises PT

(+) ETRM (+8.1%) 15 centers now certified to implant, administer obesity, metabolic disease treatment

(+) PAY (+2.5%) Stifel Nicolaus upgrades to buy vs hold; sets $42 PT

(+) RYAAY (+4.2%) Reports 28% increase in March traffic

(+) ARNA (+5.1%) Gets additional patent for weight management treatment

(+) CTSO (+2.2%) 2015 sales to compare 'favorably' with 2014


(-) GM (-1.8%) Canada government to sell nearly 73.4 million shares in co

(-) GEL (-6.1%) Prices sale of 4 million shares at $44.42 each

(-) CERU (-2.3%) Prices sale of 5.84 million shares at $6.00 each

(-) HPP (-2.2%) Upsizes shareholders' sale of stock to 5.3 million from 5.0 million

(-) AXP (-1.1%) Oppenheimer downgrades to underperform vs perform

(-) ALJ (-1.0%) Credit Suisse downgrades to neutral vs outperform

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 All rights reserved. Unauthorized reproduction is strictly prohibited.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos


    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More